Miracor Medical Systems GmbH Granted Several U.S. Patents for its PICSO® System to Treat Severe Heart Attack Patients

VIENNA--(BUSINESS WIRE)--Miracor Medical Systems GmbH announced today that it has been granted three new U.S. patents covering a unique dual balloon method and the new “Wien Algorithm” of its novel PICSO® (Pressure-controlled Intermittent Coronary Sinus Occlusion) system that ensures a stable and repeatable PICSO® treatment designed to improve myocardial perfusion following primary PCI (Percutaneous Coronary Intervention, or angioplasty). (Click here for video animation of PICSO®.)

Back to news